Sayer Ji
Founder of GreenMedInfo.com

Subscribe to our informative Newsletter & get two FREE E-Books

Our newsletter serves 500,000 with essential news, research & healthy tips, daily.

Depression: 21st Century Solutions + The Dark Side of Wheat

n/a
Abstract Title:

Vitamin D inhibits pro-inflammatory T cell function in patients with inflammatory bowel disease.

Abstract Source:

J Crohns Colitis. 2019 May 4. Epub 2019 May 4. PMID: 31051495

Abstract Author(s):

Josefine Schardey, Anna-Maria Globig, Christine Janssen, Maike Hofmann, Philipp Manegold, Robert Thimme, Peter Hasselblatt

Article Affiliation:

Josefine Schardey

Abstract:

BACKGROUND AND AIMS: Dysregulated T cell responses contribute to the pathogenesis of inflammatory bowel disease (IBD). Since vitamin D (vitD) deficiency is a risk factor for adverse disease outcomes, we aimed to characterize the impact of vitD on intestinal and peripheral T cell profiles.

METHODS: T cells were isolated from peripheral blood and intestinal biopsies of IBD patients, incubated with vitD and characterized by flow cytometry. To translate these in vitro findings to the clinic, serum vitD concentrations and clinical outcomes were correlated with T cell phenotype and function in a prospective patient cohort.

RESULTS: Incubation of peripheral and intestinal T cells with 1,25(OH)2-vitD resulted in strongly reduced frequencies of pro-inflammatory CD4+ and CD8+ T cells producing IFNγ, IL-17, IL-22, IL-9 and TNF. Univariable analysis of 200 IBD patients revealed associations of vitD deficiency with incompliant vitD intake, season of the year and anemia in Crohn's disease (CD) as well as disease activity in ulcerative colitis (UC). Ex vivo immuno-phenotyping revealed that CD4+and CD8+ T cell subsets were not substantially altered in vitD-deficient vs. -sufficient patients while regulatory T cell frequencies were reduced in UC and non-smoking CD patients with vitD deficiency. However, normalization of serum vitD concentrations in previously deficient CD patients resultedin significantly reduced frequencies of CD4+ T cells producing IFNγ, IL-17 and IL-22.

CONCLUSION: VitD exerts profound anti-inflammatory effects on peripheral and intestinal CD4+ and CD8+ T cells of IBD patients in vitro and inhibits TH1 and TH17 cytokine production in CD patients in vivo.

Study Type : Human Study

Print Options


Key Research Topics

Sayer Ji
Founder of GreenMedInfo.com

Subscribe to our informative Newsletter & get two FREE E-Books

Our newsletter serves 500,000 with essential news, research & healthy tips, daily.

Depression: 21st Century Solutions + The Dark Side of Wheat

This website is for information purposes only. By providing the information contained herein we are not diagnosing, treating, curing, mitigating, or preventing any type of disease or medical condition. Before beginning any type of natural, integrative or conventional treatment regimen, it is advisable to seek the advice of a licensed healthcare professional.

© Copyright 2008-2019 GreenMedInfo.com, Journal Articles copyright of original owners, MeSH copyright NLM.